These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11112984)

  • 1. Hepatic glucokinase promoter polymorphism is associated with hepatic insulin resistance in Asian Indians.
    Chiu KC; Chuang LM; Yoon C; Saad MF
    BMC Genet; 2000; 1():2. PubMed ID: 11112984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A variation at position -30 of the beta-cell glucokinase gene promoter is associated with reduced beta-cell function in middle-aged Japanese-American men.
    Stone LM; Kahn SE; Fujimoto WY; Deeb SS; Porte D
    Diabetes; 1996 Apr; 45(4):422-8. PubMed ID: 8603762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A -30G>A polymorphism of the beta-cell-specific glucokinase promoter associates with hyperglycemia in the general population of whites.
    Rose CS; Ek J; Urhammer SA; Glümer C; Borch-Johnsen K; Jørgensen T; Pedersen O; Hansen T
    Diabetes; 2005 Oct; 54(10):3026-31. PubMed ID: 16186409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucokinase gene islet promoter region variant (G-->A) at nucleotide -30 is not associated with reduced insulin secretion in Finns.
    Rissanen J; Saarinen L; Heikkinen S; Kekäläinen P; Mykkänen L; Kuusisto J; Deeb SS; Laakso M
    Diabetes Care; 1998 Jul; 21(7):1194-7. PubMed ID: 9653619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the glucokinase gene promoter polymorphism -30G > A (rs1799884) with gestational diabetes mellitus susceptibility: a case-control study and meta-analysis.
    Han X; Cui H; Chen X; Xie W; Chang Y
    Arch Gynecol Obstet; 2015 Aug; 292(2):291-8. PubMed ID: 25633883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the impact of a liver glucokinase promoter variant on glucose tolerance and insulin sensitivity index.
    Urhammer SA; Hansen T; Jensen LB; Clausen JO; Hansen L; Chui KC; Pedersen O
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1786-9. PubMed ID: 9177383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes.
    Elbein SC; Sun J; Scroggin E; Teng K; Hasstedt SJ
    Diabetes Care; 2001 Mar; 24(3):472-8. PubMed ID: 11289470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygosity for a common polymorphism in the islet-specific promoter of the glucokinase gene is associated with a reduced early insulin response to oral glucose in pregnant women.
    Zaidi FK; Wareham NJ; McCarthy MI; Holdstock J; Kalloo-Hosein H; Krook A; Swinn RA; O'Rahilly S
    Diabet Med; 1997 Mar; 14(3):228-34. PubMed ID: 9088772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease.
    Bechmann LP; Gastaldelli A; Vetter D; Patman GL; Pascoe L; Hannivoort RA; Lee UE; Fiel I; Muñoz U; Ciociaro D; Lee YM; Buzzigoli E; Miele L; Hui KY; Bugianesi E; Burt AD; Day CP; Mari A; Agius L; Walker M; Friedman SL; Reeves HL
    Hepatology; 2012 Apr; 55(4):1083-93. PubMed ID: 22095588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of Japanese men with glucokinase gene beta-cell promoter variant.
    Yamada K; Yuan X; Ishiyama S; Ichikawa F; Koyama KI; Koyanagi A; Koyama W; Nonaka K
    Diabetes Care; 1997 Jul; 20(7):1159-61. PubMed ID: 9203455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucokinase gene variations in Japanese-Americans with a family history of NIDDM.
    Stone LM; Kahn SE; Deeb SS; Fujimoto WY; Porte D
    Diabetes Care; 1994 Dec; 17(12):1480-3. PubMed ID: 7882822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of hepatic Gck promoter in ageing rats contributes to diabetogenic potential.
    Jiang MH; Fei J; Lan MS; Lu ZP; Liu M; Fan WW; Gao X; Lu DR
    Diabetologia; 2008 Aug; 51(8):1525-33. PubMed ID: 18496667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TNF-alpha gene NcoI polymorphism at position -308 of the promoter influences insulin resistance, and increases serum triglycerides after postprandial lipaemia in familiar obesity.
    Wybrańska I; Malczewska-Malec M; Niedbał S; Naskalski JW; Dembińska-Kieć A
    Clin Chem Lab Med; 2003 Apr; 41(4):501-10. PubMed ID: 12747594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Frequency Genetic Variant in the Hepatic Glucokinase Gene Is Associated With Type 2 Diabetes and Insulin Resistance in Chinese Population.
    Ma Y; Luo Y; Gong S; Zhou X; Li Y; Liu W; Zhang S; Cai X; Ren Q; Zhou L; Zhang X; Wang Y; Huang X; Gao X; Hu M; Han X; Ji L
    Diabetes; 2021 Mar; 70(3):809-816. PubMed ID: 33298402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic regulation of birth weight and fasting glucose by a common polymorphism in the islet cell promoter of the glucokinase gene.
    Weedon MN; Frayling TM; Shields B; Knight B; Turner T; Metcalf BS; Voss L; Wilkin TJ; McCarthy A; Ben-Shlomo Y; Davey Smith G; Ring S; Jones R; Golding J; Byberg L; Mann V; Axelsson T; Syvänen AC; Leon D; Hattersley AT
    Diabetes; 2005 Feb; 54(2):576-81. PubMed ID: 15677518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucokinase gene variants in subjects with late-onset NIDDM and impaired glucose tolerance.
    Laakso M; Malkki M; Kekäläinen P; Kuusisto J; Mykkänen L; Deeb SS
    Diabetes Care; 1995 Mar; 18(3):398-400. PubMed ID: 7555485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive association in the absence of linkage suggests a minor role for the glucokinase gene in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus amongst south Indians.
    McCarthy MI; Hitchins M; Hitman GA; Cassell P; Hawrami K; Morton N; Mohan V; Ramachandran A; Snehalatha C; Viswanathan M
    Diabetologia; 1993 Jul; 36(7):633-41. PubMed ID: 8359581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid binding protein 2 and insulin resistance.
    Chiu KC; Chuang LM; Chu A; Yoon C
    Eur J Clin Invest; 2001 Jun; 31(6):521-7. PubMed ID: 11422402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G/A polymorphism at -258 of the hepatic glucokinase promoter is not associated with decreased birth weight in preterm neonates.
    Pawlowski M; Kouklinos A; Jopp-Petzina G; Herkenrath P; Fischer M; Kribs A; Roth B; Roth J; Tenbrock K
    Neonatology; 2008; 94(2):71-4. PubMed ID: 18196929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.